Decoding the spatiotemporal dynamics of T cell immune landscapes in glioblastoma: remodeling precision combination therapies [0.03%]
解码胶质母细胞瘤T细胞免疫景观的时空动态:重塑精准联合治疗
Qingya Qiu,Tingjun Zhang,Ping Song et al.
Qingya Qiu et al.
The profound intratumoral heterogeneity and the highly dynamic spatiotemporal evolution of its immunosuppressive microenvironment in glioblastoma (GBM) are major factors underlying the limited efficacy of the standard-of-care treatment (SOC...
Universal CAR-T cell therapy: mechanisms and evasion strategies of bidirectional immune rejection [0.03%]
通用型CAR-T细胞治疗:双向免疫排斥机制与逃逸策略
Lu Ding,Lianfeng Zhao,Mengting Zhang et al.
Lu Ding et al.
While autologous chimeric antigen receptor (CAR)-T cell therapies have revolutionized the treatment of hematological malignancies, their widespread clinical application remains constrained by lengthy manufacturing cycles, prohibitive costs,...
Novel immunotherapeutic strategies for colorectal cancer treatment: Advances, challenges, and future directions [0.03%]
结直肠癌免疫治疗新策略:进展、挑战与未来方向
Engeng Chen,Gaoyang Cao,Zhangfa Song
Engeng Chen
Immunotherapy has reshaped the treatment landscape of colorectal cancer (CRC), with the clearest and most durable benefit established in mismatch repair-deficient (dMMR)/microsatellite instability-high (MSI-H) disease. However, framing CRC ...
Macrophages as central mediators of perineural invasion in cancer: Implications for pain and prognosis [0.03%]
巨噬细胞在癌症周缘神经侵犯中的中心作用:对疼痛和预后的意义
Shiji Cheng,Yuze Hua,Quan Liao et al.
Shiji Cheng et al.
Perineural invasion (PNI) is associated with tumor progression, therapeutic resistance, and poor prognosis. However, the mechanisms driving tumor-nerve interactions remain incompletely understood. Emerging evidence suggests that macrophages...
The hypusine circuit: eIF5A at the crossroads of polyamine metabolism, malignant progression, and therapeutic vulnerability [0.03%]
Hypusine回路:eIF5A在聚胺代谢、恶性进展和治疗弱点的交汇点
Zhihao Wen,Zhaoyang Zeng,Wei Xiong et al.
Zhihao Wen et al.
Hypusination of eukaryotic translation initiation factor 5 A (eIF5A) is a highly conserved post-translational modification. This process uniquely depends on spermidine and is catalyzed sequentially by deoxyhypusine synthase (DHPS) and deoxy...
Tao Zhang,Nian Chen,Jun Wang et al.
Tao Zhang et al.
Glioblastoma (GBM) is the most aggressive type of primary brain tumor, and recurrence remains virtually inevitable despite standard treatment. The prevention of recurrence represents a critical unmet need. However, the evolutionary characte...
Targeting the integrated stress response to overcome cancer therapy resistance: From mechanisms to therapeutic opportunities [0.03%]
针对整合应激反应克服癌症治疗耐药性:从机制到治疗机会
Chenliang Zhang,Liping Li,Ting Zhang
Chenliang Zhang
Drug resistance remains a major obstacle in cancer therapy, underscoring the urgent need to identify new targets and therapeutic strategies to overcome resistance. The integrated stress response (ISR), an evolutionarily conserved mechanism ...
Alaa Ibrahim,Maha Nasr
Alaa Ibrahim
Chimeric antigen receptor (CAR)-T cell immunotherapy is one of the emerging advancements in personalized treatment of cancer, whose design is based on the genetic modification of T cells to express chimeric antigen receptors (CARs) to gener...
Drug resistance in breast cancer brain metastasis: mechanisms and therapeutic strategies [0.03%]
乳腺癌脑转移的耐药机制及治疗策略
Paromita Sarker,Shreyas S Rao
Paromita Sarker
Brain-metastatic breast cancer (BMBC) is a severe complication of advanced breast cancer, affecting 15-30% of metastatic patients, particularly those with HER2-positive or triple-negative subtypes, and is associated with dismal prognosis an...
Dynamic protein trafficking shapes ferroptosis sensitivity and immunogenicity [0.03%]
蛋白质动态运输调节细胞对铁死亡的敏感性和免疫原性
Wanxin Guo,Jingyi Lu,Zijie Liu et al.
Wanxin Guo et al.
Ferroptosis is generally described as a regulated form of cell death associated with metabolic dysregulation and iron-dependent lipid peroxidation. Beyond gene expression and enzymatic activity, accumulating evidence indicates that ferropto...